Publications
Securities Class Actions in the Life Sciences Sector
Spring 2025
Sidley is pleased to present its annual review addressing developments in securities class actions brought against life sciences companies in 2024.
In this publication, we begin with an overview and analysis of trends in federal district court and appellate decisions in these cases. We then provide summaries of the 49 decisions surveyed. Finally, we catalog the new securities class action complaints filed against life sciences companies in 2024.
Click here to download the PDF.
Click here to view a two-page summary.
Click here to order hard copies. Limited supply available.
Knowledge Management Lawyer Zarine Alam also contributed to the 2024 annual report.
Contacts
Seattle
+1 415 439 1799Seattle
Capabilities
Suggested News & Insights
Life Sciences College 2026Thursday, February 12, 2026Sidley Represents Vivo Capital on Its Acquisition of Dutscher GroupFebruary 4, 2026Sidley Represents AdvanCell in Collaboration and Exclusive Licensing Agreement With 48Hour DiscoveryFebruary 3, 2026Sidley Represents RoundTable Healthcare Partners in Its Partnership and Investment in ColorescienceFebruary 2, 2026U.S. Clinical Trial Design & Execution RisksThursday, January 29, 2026Sidley Represents Simcere in €1 Billion Licensing and Collaboration Agreement With Boehringer IngelheimJanuary 29, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory